Copper-specific damage in human erythrocytes exposed to oxidative stress

Biological Trace Element Research

Volumn 56, Issue 2, 1997, Pages 231-240

  Clopton, David A ^a   Saltman, Paul ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

copper; hemoglobin; human erythrocytes; iron; NADH methemoglobin reductase; Oxidative stress

Indexed keywords

ASCORBIC ACID; COPPER COMPLEX; CYTOCHROME B5 REDUCTASE; FERRIC ION; HEMOGLOBIN; IRON COMPLEX; METHEMOGLOBIN; OXYGEN RADICAL;

ARTICLE; CELL DAMAGE; CONTROLLED STUDY; ERYTHROCYTE; HEMOLYSATE; HUMAN; HUMAN CELL; OXIDATIVE STRESS;

EID: 0030988276     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02785396     Document Type: Article

References (48)

1. B. Halliwell and J. M. C. Gutteridge, Role of free radicals and catalytic metal ions in human disease: an overview, Methods Enzymol. 186, 1-85 (1990).
2. W. Pryor, Free radical biology: Xenobiotics, cancer, and aging, Ann. NY Acad. Sci. 393, 1-22 (1982).
3. P. Saltman, Oxidative stress: a radical view, Semin. Hematol. 26, 249-256 (1989).
4. M. Chevion, A site-specific mechanism for free radical induced biological damage: the essential role of redox-active transition metals, Free Rad. Biol. Med. 5, 27-37 (1988).
5. E. Shinar, T. Navok, and M. Chevion, The analogous mechanisms of enzymatic inactivation induced by ascorbate and Superoxide in the presence of copper, J. Biol. Chem. 258, 14,778-14,783 (1983).
6. E. R. Stadtman, Metal ion-catalyzed oxidation of proteins: biochemical mechanism and biological consequences, Free Rad. Biol. Med. 9, 315-325 (1990).
7. B. Van Dyke, D. A. Clopton, and P. Saltman, Buffer-induced anomalies in the Fenton chemistry of iron and copper, Inorg. Chim. Acta 242-243, 1-5 (1996).
8. R. L. Levine, Oxidative modification of glutamine synthetase. I. Inactivation is due to loss of one histidine residue, J. Biol. Chem. 258, 11,823-11,827 (1983).
9. R. L. Levine, Oxidative modification of glutamin synthetase. II. Characterization of the ascorbate model system, J. Biol. Chem. 258, 11,828-11,833 (1983).
10. G. Marx and M. Chevion, Site specific modification of albumin by free radicals. Reaction of copper(II) and ascorbate, Biochem. J. 236, 397-400 (1986).
11. J. Masuoka and P. Saltman, Zinc(II) and copper(II) binding to serum albumin. A comparative study of dog, bovine, and human albumin, J. Biol. Chem. 269, 25,557-25,561 (1994).
12. E. A. Rachmilewitz, E. Shinar, O. Shalev, U. Galilli, and S. L. Schrier, Erythrocyte membrane alterations in beta-thalassemia, Clin. Haematol. 14, 163-182 (1985).
13. E. Shinar, O. Shalev, E. A. Rachmilewitz, and S. L. Schrier, Erythrocyte membrane skeleton abnormalities in severe beta-thalassemia, Blood 70, 158-164 (1987).
14. R. P. Hebbel, Autooxidation and a membrane-associated "Fenton reagent" a possible explanation for development of membrane lesions in sickle erythrocytes, Clin. Haematol. 14, 129-140 (1985).
15. R. P. Hebbel and J. W. Eaton, Pathobiology of heme interaction with the erythrocyte membrane, Semin. Hematol. 26, 136-149 (1989).
16. R. P. Hebbel, W. T. Morgan, J. W. Eaton, and B. E. Hedlund, Accelerated autoxidation and heme loss due to instability of sickle hemoglobin, Proc. Natl. Acad. Sci. USA 85, 237-241 (1988).
17. T. Repka, O. Shalev, R. Reddy, J. Yuan, A. Abrahamov, E. A. Rachmilewitz, P. S. Low, and R. P. Hebbel, Non-random association of free iron with membranes of sickle and beta-thalassemic erythrocytes, Blood 82, 3204-3210 (1993).
18. M. M. Kay, G. J. Bosman, S. S. Shapiro, A. Bendich, and P. S. Bassel, Oxidation as a possible mechanism of cellular aging: Vitamin E deficiency causes premature aging and IgG binding to erythrocytes, Proc. Natl. Acad. Sci. USA 83, 2463-2467 (1986).
19. M. M. Kay, T. Wyant, and J. Goodman, Autoantibodies to band 3 during aging and disease and aging interventions, Ann. NY Acad. Sci. 719, 419-447 (1994).
20. S. K. Jain, Evidence for membrane lipid peroxidation during the in vivo aging of human erythrocytes, Biochim. Biophys. Acta 937, 205-210 (1988).
21. P. S. Low and R. Kannan, Effect of hemoglobin denaturation on membrane structure and IgG binding role in red cell aging, Prog. Clin. Biol. Res. 319, 525-546 (1989).
22. E. Shinar, E. A. Rachmilewitz, A. Shifter, E. Rahamin, and P. Saltman, Oxidative damage to human red cells induced by copper and iron complexes in the presence of ascorbate, Biochim. Biophys. Acta 1014, 66-72 (1989).
23. L. A. Eguchi and P. Saltman, Kinetics and mechanisms of metal reduction by hemoglobin 1. Reduction of iron (III) complexes, Inorg. Chem. 26, 3665-3669 (1987).
24. L. A. Eguchi and P. Saltman, Kinetics and mechanisms of metal reduction by hemoglobin. 2. Reduction of copper(II) complexes, Inorg. Chem. 26, 3669-3672 (1987).
25. C. C. Winterbourn and R. W. Carrell, Oxidation of human haemoglobin by copper. Mechanism and suggested role of the thiol group of residue β-93, Biochem. J. 165, 141-148 (1977).
26. A. Mansouri and A. A. Lurie, Concise review: methemoglobinemia, Am. J. Hematol. 42, 7-12 (1993).
27. C. R. Zerez, N. A. Lachant, and K. R. Tanaka, Impaired erythrocyte methemoglobin reduction in sickle cell disease: dependence of methemoglobin reduction on reduced nicotinamide adenine dinucleotide content, Blood 76, 1008-1014 (1990).
28. M. Boulard, K.-G. Blume, and E. Beutler, The effect of copper on red cell enzyme activities, J. Clin. Invest. 51, 459-461 (1972).
29. S. J. Forman, K. S. Kumar, A. G. Redeker, and P. Hochstein, Hemolytic anemia in Wilson disease: clinical findings and biochemical methods, Am. J. Hematol. 9, 269-275 (1980).
30. E. Baysal and C. A. Rice-Evans, Modulation of iron-mediated oxidant damage in erythrocytes by cellular energy levels, Free Rad. Res. Commun. 3, 227-232 (1987).
31. A. Deiss, G. R. Lee, and G. E. Cartwright, hemolytic anemia in Wilson's disease, Ann. Intern. Med. 73, 413-418 (1970).
32. J. P. Flikweert, R. K. J. Hoorn, and G. E. J. Staal, The effect of copper on human erythrocyte glutathione reductase, Int. J. Biochem. 5, 649-653 (1974).
33. N. Shaklai, V. S. Sharma, and H. M. Ranney, Interaction of sickle cell hemoglobin with erythrocyte membranes, Proc. Natl. Acad. Sci. USA 78, 65-68 (1981).
34. E. Baysal, S. G. Sullivan, and A. Stern, Binding of iron to human red cell membranes, Free Rad. Res. Commun. 8, 55-59 (1989).
35. C. N. Oliver, B-W. Ahn, E. J. Moreman, S. Goldstein, and E. R. Stadtman, Age-related changes in oxidized proteins, J. Biol. Chem. 262, 5488-5491 (1987).
36. D. R. Thorburn and E. Beutler, Decay of hexokinase during reticulocyte maturation is oxidative damage a signal for destruction?, Biochem. Biophys. Res. Commun. 162, 612-618 (1989).
37. V. Stocchi, B. Biagiarelli, M. Fiorani, F. Palma, G. Piccoli, L. Cucchiarini, and M. Dacha, Inactivation of rabbit red blood cell hexokinase activity promoted in vitro by an oxygen-radical- generating system, Arch. Biochem. Biophys. 311, 160-167 (1994).
38. L. Fucci, C. N. Oliver, M. J. Coon, and E. R. Stadtman, Inactivation of key metabolic enzymes by mixed-function oxidation reactions: possible implication in protein turnover and ageing, Proc. Natl. Sci. USA 80, 1521-1525 (1983).
39. J. Masuoka, J. Hegenauer, B. R. van Dyke, and P. Saltman, Intrinsic stochiometric equilibrium constants for the binding of zinc(II) and copper(II) to the high affinity site of serum albumin, J. Biol. Chem. 268, 21,533-21,537 (1993).
40. T. G. Spiro and P. Saltman, Polynuclear complexes of iron and their biological implications, in Structure and Bonding, vol. 6, P. Hemmerich, C. K. Jorgensen, J. B. Neilands, R. S. Nyholm, D. Reinen, and R. J. P. Williams, eds., Springer-Verlag, New York, pp. 117-156 (1969).
41. E. Beutler, The preparation of red cells for assay, in Red Cell Metabolism. A Manual of Biochemical Techniques, 3rd ed, Grune & Stratton, Orlando, pp. 8-18 (1984).
42. E. J. Van Kampen and W. G. Zijlstra, Determination of hemoglobin and its derivatives, Adv. Clin. Chem. 8, 141-187 (1965).
43. C. C. Winterbourn, Oxidative reactions of hemoglobin, Methods Enzymol. 186, 265-272 (1990).
44. E. Hegesh, N. Gruener, S. Cohen, R. Bochkovsky, and H. I. Shuval, A sensitive micromethod for the determination of methemoglobin in blood, Clin. Chim. Acta 30, 679-682, (1970).
45. E. Beutler, NADH methemoglobin reductase (NADH-ferricyanide reductase), in Red Cell Metabolism. A Manual of Biochemical Techniques, 3rd ed., Grune & Stratton, Orlando, pp. 82, 83 (1984).
46. 5 reductase from human erythrocytes, Biochim. Biophys. Acta 275, 62-73 (1972).
47. D. Gelvan and P. Saltman, Different cellular targets for Cu- and Fe-catalyzed oxidation observed using a Cu-compatible thiobarbituric acid assay, Biochim. Biophys. Acta 1035, 353-360 (1990).
48. C. A. Rice-Evans and E. Baysal, Iron-mediated oxidative stress in erythrocytes, Biochem. J. 244, 191-196 (1987).